Vantage Foundation Donates HK$1 Million to Support Residents Affected by Hong Kong Fire
HONG KONG, Nov. 29, 2025 /PRNewswire/ --Â Vantage Foundation has donated HK$1 million…
Over HK$100 Million Donated by Multiple Web3 FinTech Companies to Support Fire Victims
HONG KONG, Nov. 29, 2025 /PRNewswire/ --Â On November 26, a severe Level-5…
uniQure to Announce Third Quarter 2025 Financial Results
LEXINGTON, Mass. and AMSTERDAM, Nov. 06, 2025 (GLOBE NEWSWIRE) -- uniQure N.V.…
Denifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology Conference
October 24, 2025 07:00 ET Â | Source: Sagimet Biosciences Inc. Denifanstat met…
Sanofi Hosts Regional Webinar on Protecting High-Risk Groups from Seasonal Influenza
Sanofi recently hosted a hybrid symposium titled "Safeguarding High-Risk Groups: The Importance…
School Meals Save Lives and Strengthen Communities
On World Food Day, Education Cannot Wait calls for increased investment in…
36-Year-Old Man Given a Second Chance at Life With Advanced Heart Pump
INDORE, India, Oct. 9, 2025 /PRNewswire/ --Â At Apollo Rajshree Hospitals, a 36-year-old…
Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints
SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd…
EURneffy (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
EURneffy (neffy® in the U.S.) offers a new delivery method for adrenaline…
Shepherd Partners with Intel to Enhance its Endpoint Protection Suite with Hardware-based Ransomware Detection
Shepherd, a leading IoT and enterprise endpoint security and management vendor headquartered…